These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24495789)

  • 1. Editorial on "modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization" by K. Sandra, I. Vandenheede and P. Sandra.
    Fanali S
    J Chromatogr A; 2014 Mar; 1335():80. PubMed ID: 24495789
    [No Abstract]   [Full Text] [Related]  

  • 2. Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization.
    Sandra K; Vandenheede I; Sandra P
    J Chromatogr A; 2014 Mar; 1335():81-103. PubMed ID: 24365115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in biopharmaceutical analysis in the People's Republic of China: 1991-1993.
    Qin Z
    J Pharm Biomed Anal; 1995 Jan; 13(1):1-7. PubMed ID: 7718628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in biopharmaceutical analysis in the People's Republic of China: 1993-1995.
    Qin ZL
    J Pharm Biomed Anal; 1996 Aug; 14(11):1395-403. PubMed ID: 8877845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural mass spectrometry in biologics discovery: advances and future trends.
    Mo J; Tymiak AA; Chen G
    Drug Discov Today; 2012 Dec; 17(23-24):1323-30. PubMed ID: 22819924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical characterization of biopharmaceuticals.
    Parr MK; Montacir O; Montacir H
    J Pharm Biomed Anal; 2016 Oct; 130():366-389. PubMed ID: 27324698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in native high-performance liquid chromatography and intact mass spectrometry for the characterization of biopharmaceutical products.
    Tassi M; De Vos J; Chatterjee S; Sobott F; Bones J; Eeltink S
    J Sep Sci; 2018 Jan; 41(1):125-144. PubMed ID: 28990739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical proteins: opportunities and challenges.
    Birch JR; Onakunle Y
    Methods Mol Biol; 2005; 308():1-16. PubMed ID: 16082021
    [No Abstract]   [Full Text] [Related]  

  • 9. Biopharmaceutical statistics beyond 2000.
    Gould AL
    J Biopharm Stat; 2001; 11(1-2):1-8. PubMed ID: 11459439
    [No Abstract]   [Full Text] [Related]  

  • 10. Biopharmaceutical drug discovery using novel protein scaffolds.
    Gill DS; Damle NK
    Curr Opin Biotechnol; 2006 Dec; 17(6):653-8. PubMed ID: 17055245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro total analysis systems in biopharmaceutical process development.
    Chen X
    Bioanalysis; 2009 Oct; 1(7):1183-6. PubMed ID: 21083042
    [No Abstract]   [Full Text] [Related]  

  • 12. Ion-exchange chromatography for the characterization of biopharmaceuticals.
    Fekete S; Beck A; Veuthey JL; Guillarme D
    J Pharm Biomed Anal; 2015 Sep; 113():43-55. PubMed ID: 25800161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
    Bronsema KJ; Bischoff R; van de Merbel NC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
    Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual metals cause variability in methionine oxidation measurements in protein pharmaceuticals using LC-UV/MS peptide mapping.
    Zang L; Carlage T; Murphy D; Frenkel R; Bryngelson P; Madsen M; Lyubarskaya Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():71-6. PubMed ID: 22483985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of MALDI TOF MS in biopharmaceutical research.
    Kafka AP; Kleffmann T; Rades T; McDowell A
    Int J Pharm; 2011 Sep; 417(1-2):70-82. PubMed ID: 21147205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 18. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes.
    Chhatre S; Francis R; O'Donovan K; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Bioprocess Biosyst Eng; 2007 Jan; 30(1):1-11. PubMed ID: 17093973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutical production in plants: problems, solutions and opportunities.
    Gomord V; Chamberlain P; Jefferis R; Faye L
    Trends Biotechnol; 2005 Nov; 23(11):559-65. PubMed ID: 16168504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities.
    Polli JE; Yu LX; Cook JA; Amidon GL; Borchardt RT; Burnside BA; Burton PS; Chen ML; Conner DP; Faustino PJ; Hawi AA; Hussain AS; Joshi HN; Kwei G; Lee VH; Lesko LJ; Lipper RA; Loper AE; Nerurkar SG; Polli JW; Sanvordeker DR; Taneja R; Uppoor RS; Vattikonda CS; Wilding I; Zhang G
    J Pharm Sci; 2004 Jun; 93(6):1375-81. PubMed ID: 15124197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.